NSE: TRANSPEK · BSE: 506687
TRANSPEK INDUSTRIES LTD
Manufactures commodity chemicals and is classified under the Chemicals & Petrochemicals industry. Reported Rs 621.199 crore of revenue in FY26 with an EBITDA margin of 18.9782% and net profit of Rs 45.6454 crore. The cost structure is dominated by raw materials at 45.0% of revenue, followed by other operating expenses at 26.4%, employee costs at 11.8%, depreciation at 7.8% and capex at 6.2% of revenue. Operates in-house research and development and quality control functions, and is certified under the Indian Chemical Council's Responsible Care initiative covering environment, health, safety and security practices. Has a wholly-owned subsidiary, Transpek Creative Chemistry Private Limited, and has submitted an Expression of Interest for a prospective manufacturing facility in Gopalpur, Odisha, which remains subject to board approval and due diligence. AR · MarketPing reader · 2026-08-02
Revenue streams, as the annual report describes them. Commodity chemicals. Commodity chemicals manufacturer with material-intensive cost structure
Exhibit 1: Financial summary, FY22–FY26 (all audited; no estimate years)
| ₹ crore · consolidated | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | 599 | 827 | 580 | 650 | 621 |
| EBITDA (ex other income) | 96 | 147 | 82 | 95 | 93 |
| margin % | 16.0 | 17.8 | 14.2 | 14.6 | 15.0 |
| Owners' profit | 0 | 0 | 0 | 0 | 0 |
| EPS, as reported (₹) | 117.09 | 149.45 | 69.03 | 87.25 | 81.72 |
| ROE % · ROCE % | 13.5 · 15.8 | 14.2 · 17.6 | 5.7 · 8.2 | 6.5 · 8.4 | 5.9 · 7.9 |
| Debt / equity (x) | 0.27 | 0.13 | 0.07 | 0.05 | 0.06 |
| Cash from operations | 47 | 111 | 98 | 135 | 78 |
| Capex | (48) | (49) | (40) | (21) | (38) |
Exhibit 2: Quarterly performance, last 8 quarters
| ₹ crore | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 152 | 163 | 170 | 165 | 154 | 160 | 158 | 148 |
| Profit before tax | 12 | 12 | 14 | 25 | 21 | 17 | 14 | 9 |
| Net profit | 9 | 10 | 11 | 19 | 16 | 13 | 11 | 7 |
| EPS (₹) | 16.63 | 17.10 | 19.06 | 34.39 | 27.90 | 22.62 | 19.42 | 11.78 |
Exhibit 3: Peers — basic industry group, by market cap
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| TATA CHEMICALS LTD | 15,351 | — | 0.69 | 139.2 | (7.7) | (5.0) | 7.4 | 14.4 |
| DEEPAK FERTILIZERS & PETR | 14,679 | 14.9 | 1.97 | 11.1 | 9.9 | 8.4 | 14.6 | 26.1 |
| GUJ NAR VAL FER & CHEM L | 7,529 | 7.3 | 0.83 | 5.4 | 8.9 | 10.3 | 8.7 | 22.1 |
| TANFAC INDUSTRIES LTD. | 6,923 | 56.6 | 18.55 | — | 18.8 | 24.3 | — | 16.0 |
| GUJARAT ALKALIES & CHEM | 4,105 | 61.8 | 0.79 | 8.7 | (0.0) | 0.7 | 12.4 | 18.4 |
| GHCL LIMITED | 3,565 | 7.8 | 1.00 | 4.7 | 13.3 | 16.6 | 1.1 | 23.9 |
| GRAUER & WEIL IND LTD | 3,543 | 21.6 | 3.28 | 14.4 | 15.2 | 19.2 | 14.5 | 20.4 |
| J.G.CHEMICALS LIMITED | 2,179 | 29.0 | 4.03 | 22.2 | 12.7 | 16.9 | — | 11.5 |
Exhibit 4: Where the company sits in its group
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/E (TTM) | 15.2 | 17.4 | 23 of 50 | 55% |
| P/B | 0.9 | 1.4 | 21 of 60 | 63% |
| ROCE | 7.0 | 6.0 | 27 of 62 | 57% |
| ROE | 6.0 | 5.0 | 28 of 60 | 54% |
| Debt / Equity | 0.1 | 0.2 | 19 of 60 | 70% |
| EBITDA margin | 14.8 | 13.3 | 23 of 58 | 61% |
| Revenue growth | (10.3) | 6.7 | 44 of 54 | 19% |
| Profit growth | (65.8) | 21.0 | 50 of 64 | 22% |
| Market cap | 693 | 98 | 18 of 66 | 74% |
Exhibit 5: Filings of the last 90 days, with the measured price reaction
| Date · filing | Category | Importance | Next day % | 5-day % |
|---|---|---|---|---|
| 19 Oct 2026 · Notice to shareholders on special window for physical share transfer | compliance | minimal | — | — |
| 6 Oct 2026 · Quarterly Compliance Certificate for Securities Dematerialisation | compliance | minimal | — | — |
| 29 Sept 2026 · ICRA reaffirms ratings on Transpek bank facilities and fixed deposits | credit debt | medium | — | — |
| 28 Sept 2026 · Trading window closure from October 1, 2026 ahead of Q2 results | compliance | minimal | — | — |
| 16 Sept 2026 · Scrutinizer Report filed for 60th AGM, all four resolutions passed | board shareholder meetings | low | — | — |
| 15 Sept 2026 · 60th AGM proceedings: 200 percent dividend, 4 resolutions tabled | board shareholder meetings | low | — | — |
| 1 Sept 2026 · Crisil Reaffirms A/Stable Rating on Bank Facilities and Fixed Deposits | credit debt | medium | — | — |
| 26 Aug 2026 · Transpek Industries to meet investors in Mumbai on Sept 3 | board shareholder meetings | low | — | — |
| 25 Aug 2026 · Transpek Q1 FY27: Revenue 155 Cr, EBITDA Down 32%, Aims to Double in 5-6 Years | investor communications | low | — | — |
| 20 Aug 2026 · Investor call recording uploaded on company website | investor communications | low | — | — |
How to read this document
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) | A state: the latest filed quarter and the measured reactions | an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
Sources, method and disclosures
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.